|
G |
Ace |
angiotensin I converting enzyme |
decreases activity |
ISO |
bioallethrin results in decreased activity of ACE protein |
CTD |
PMID:32097678 |
|
NCBI chr10:90,910,316...90,930,437
Ensembl chr10:90,910,316...90,931,131
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
ISO |
Vitamin E inhibits the reaction [bioallethrin results in increased expression of BAX protein] |
CTD |
PMID:35511042 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Casp3 |
caspase 3 |
increases cleavage multiple interactions |
ISO |
bioallethrin results in increased cleavage of CASP3 protein Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP3 protein] |
CTD |
PMID:35511042 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions increases cleavage |
ISO |
Vitamin E inhibits the reaction [bioallethrin results in increased cleavage of CASP9 protein] |
CTD |
PMID:35511042 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
decreases activity |
ISO |
bioallethrin results in decreased activity of CAT protein |
CTD |
PMID:32097678 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ces1d |
carboxylesterase 1D |
increases metabolic processing |
ISO |
CES1 protein results in increased metabolism of bioallethrin |
CTD |
PMID:19249324 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Chrm4 |
cholinergic receptor, muscarinic 4 |
multiple interactions |
ISO |
[DDT co-treated with bioallethrin] results in increased expression of CHRM4 mRNA |
CTD |
PMID:10192214 |
|
NCBI chr 3:77,893,425...77,901,166
Ensembl chr 3:77,893,425...77,901,159
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing increases expression |
ISO |
CYP3A4 protein results in increased metabolism of bioallethrin bioallethrin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:19249324 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Glo1 |
glyoxalase 1 |
increases activity |
ISO |
bioallethrin results in increased activity of GLO1 protein |
CTD |
PMID:32097678 |
|
NCBI chr20:8,663,617...8,681,661
Ensembl chr20:8,662,801...8,681,649
|
|
G |
Gsr |
glutathione-disulfide reductase |
decreases activity |
ISO |
bioallethrin results in decreased activity of GSR protein |
CTD |
PMID:32097678 |
|
NCBI chr16:58,482,209...58,525,256
Ensembl chr16:58,482,505...58,525,661
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of HMOX1 protein [Vitamin E co-treated with bioallethrin] results in increased expression of HMOX1 protein |
CTD |
PMID:35511042 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Ifng |
interferon gamma |
multiple interactions decreases expression affects expression |
ISO |
[bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IFNG protein bioallethrin results in decreased expression of IFNG mRNA bioallethrin affects the expression of IFNG protein |
CTD |
PMID:9860237 PMID:10414782 PMID:12755381 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il4 |
interleukin 4 |
multiple interactions affects expression |
ISO |
[bioallethrin co-treated with Piperonyl Butoxide] results in increased expression of IL4 protein bioallethrin affects the expression of IL4 protein |
CTD |
PMID:9860237 PMID:10414782 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of NFE2L2 protein Vitamin E inhibits the reaction [bioallethrin results in increased expression of NFE2L2 protein] |
CTD |
PMID:35511042 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
increases expression multiple interactions |
ISO |
bioallethrin results in increased expression of NQO1 protein [Vitamin E co-treated with bioallethrin] results in increased expression of NQO1 protein |
CTD |
PMID:35511042 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO EXP |
bioallethrin results in increased activity of NR1I2 protein |
CTD |
PMID:19249324 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
affects activity |
EXP |
bioallethrin affects the activity of SCN10A protein |
CTD |
PMID:19766671 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Scn1b |
sodium voltage-gated channel beta subunit 1 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 1:86,353,917...86,363,836
Ensembl chr 1:86,353,917...86,363,739
|
|
G |
Scn2b |
sodium voltage-gated channel beta subunit 2 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 8:45,425,629...45,437,765
Ensembl chr 8:45,425,629...45,437,765
|
|
G |
Scn8a |
sodium voltage-gated channel alpha subunit 8 |
multiple interactions |
EXP |
bioallethrin affects the reaction [[SCN2B protein co-treated with SCN1B protein co-treated with SCN8A protein mutant form] results in increased transport of Sodium] |
CTD |
PMID:22465659 |
|
NCBI chr 7:131,982,152...132,156,075
Ensembl chr 7:131,982,480...132,151,292
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of AR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of AR mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression multiple interactions |
ISO EXP |
Allethrins results in increased expression of BAX protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BAX mRNA |
CTD |
PMID:24055895 PMID:33396045 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression multiple interactions |
ISO EXP |
Allethrins results in decreased expression of BCL2 protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of BCL2 mRNA |
CTD |
PMID:24055895 PMID:25072698 PMID:33396045 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Brdt |
bromodomain testis associated |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of BRDT mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of BRDT mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of BRDT mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr14:2,421,094...2,445,842
Ensembl chr14:2,387,796...2,445,842
|
|
G |
Cacna1a |
calcium voltage-gated channel subunit alpha1 A |
multiple interactions |
EXP |
Allethrins inhibits the reaction [CACNA1A protein results in increased transport of Calcium] |
CTD |
PMID:14634047 |
|
NCBI chr19:23,520,741...23,819,971
Ensembl chr19:23,520,741...23,823,225
|
|
G |
Cacna1c |
calcium voltage-gated channel subunit alpha1 C |
multiple interactions |
EXP |
Allethrins inhibits the reaction [CACNA1C protein results in increased transport of Calcium] |
CTD |
PMID:14634047 |
|
NCBI chr 4:151,764,138...152,379,454
Ensembl chr 4:151,764,138...152,379,648
|
|
G |
Cacna1g |
calcium voltage-gated channel subunit alpha1 G |
multiple interactions |
EXP |
Allethrins inhibits the reaction [CACNA1G protein results in increased transport of Calcium] |
CTD |
PMID:14634047 |
|
NCBI chr10:79,354,998...79,422,960
Ensembl chr10:79,355,008...79,422,752
|
|
G |
Casp3 |
caspase 3 |
increases activity decreases expression |
ISO EXP |
Allethrins results in increased activity of CASP3 protein Allethrins results in decreased expression of CASP3 protein |
CTD |
PMID:24055895 PMID:25072698 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CASP9 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
affects activity multiple interactions |
EXP |
Allethrins affects the activity of CAT protein [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of CAT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of CAT protein |
CTD |
PMID:23595975 PMID:25072698 PMID:33396045 PMID:35678313 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cd9 |
CD9 molecule |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CD9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CD9 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 4:158,256,328...158,289,136
Ensembl chr 4:158,256,328...158,289,222
|
|
G |
Ciita |
class II, major histocompatibility complex, transactivator |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CIITA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CIITA mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr10:5,139,947...5,187,493
Ensembl chr10:5,140,178...5,187,440
|
|
G |
Clu |
clusterin |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CLU mRNA |
CTD |
PMID:33051911 |
|
NCBI chr15:40,161,068...40,200,315
Ensembl chr15:40,174,617...40,200,315
|
|
G |
Creb1 |
cAMP responsive element binding protein 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of CREB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CREB1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 9:65,903,511...65,972,562
Ensembl chr 9:65,903,547...65,970,816
|
|
G |
Crebbp |
CREB binding protein |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CREBBP mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREBBP mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr10:11,335,551...11,461,888
Ensembl chr10:11,335,953...11,461,888
|
|
G |
Crem |
cAMP responsive element modulator |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CREM mRNA |
CTD |
PMID:33396045 |
|
NCBI chr17:54,238,889...54,305,989
Ensembl chr17:54,239,030...54,305,989
|
|
G |
Cybb |
cytochrome b-245 beta chain |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYBB mRNA |
CTD |
PMID:33396045 |
|
NCBI chr X:13,360,583...13,392,517
Ensembl chr X:13,359,430...13,392,586
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of CYP11A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of CYP11A1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP17A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of CYP19A1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of CYP19A1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
EXP |
Allethrins results in increased expression of and results in increased activity of CYP2E1 protein |
CTD |
PMID:22080754 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
EXP |
Allethrins results in increased expression of and results in increased activity of CYP3A2 protein |
CTD |
PMID:22080754 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Dazap1 |
DAZ associated protein 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DAZAP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DAZAP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 7:9,423,673...9,448,116
Ensembl chr 7:9,424,178...9,538,818
|
|
G |
Ddx25 |
DEAD-box helicase 25 |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of DDX25 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX25 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX25 mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr 8:33,894,224...33,910,377
Ensembl chr 8:33,894,232...33,921,764
|
|
G |
Ddx3y |
DEAD box helicase 3, Y-linked |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DDX3Y mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DDX3Y mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr Y:1,115,095...1,135,754
Ensembl chr Y:1,116,309...1,135,706
|
|
G |
Defb22 |
defensin beta 22 |
decreases expression |
EXP |
Allethrins results in decreased expression of DEFB22 mRNA |
CTD |
PMID:23595975 |
|
NCBI chr 3:140,957,093...140,961,373
Ensembl chr 3:140,957,090...140,961,373
|
|
G |
Dnmt1 |
DNA methyltransferase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT1 mRNA |
CTD |
PMID:33051911 |
|
NCBI chr 8:19,440,611...19,486,659
Ensembl chr 8:19,440,611...19,486,659
|
|
G |
Dnmt3a |
DNA methyltransferase 3 alpha |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3A mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of DNMT3A mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 6:26,791,517...26,902,161
Ensembl chr 6:26,822,609...26,896,687
|
|
G |
Dnmt3b |
DNA methyltransferase 3 beta |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of DNMT3B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of DNMT3B mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 3:142,130,592...142,169,124
Ensembl chr 3:142,130,592...142,169,124
|
|
G |
Ep300 |
E1A binding protein p300 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of EP300 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of EP300 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 7:113,108,476...113,178,529
Ensembl chr 7:113,106,247...113,136,088 Ensembl chr 7:113,106,247...113,136,088
|
|
G |
Ezh2 |
enhancer of zeste 2 polycomb repressive complex 2 subunit |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of EZH2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of EZH2 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 4:76,624,399...76,687,362
Ensembl chr 4:76,624,399...76,687,362
|
|
G |
Fshr |
follicle stimulating hormone receptor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of FSHR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of FSHR mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 6:5,198,825...5,406,785
Ensembl chr 6:5,198,825...5,406,785
|
|
G |
Gata4 |
GATA binding protein 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of GATA4 mRNA |
CTD |
PMID:33051911 |
|
NCBI chr15:37,459,601...37,531,291
Ensembl chr15:37,459,601...37,505,636
|
|
G |
Gdnf |
glial cell derived neurotrophic factor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GDNF mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of GDNF mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:56,893,992...56,919,935
Ensembl chr 2:56,895,010...56,917,209
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of GFRA1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of GFRA1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the activity of GPT protein; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased activity of GPT protein |
CTD |
PMID:33396045 PMID:35678313 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Hdac1 |
histone deacetylase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:141,853,992...141,881,057
Ensembl chr 5:141,853,989...141,881,111
|
|
G |
Hdac10 |
histone deacetylase 10 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC10 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HDAC10 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 7:120,199,126...120,205,850
Ensembl chr 7:120,199,129...120,204,228
|
|
G |
Hdac4 |
histone deacetylase 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HDAC4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HDAC4 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 9:92,503,467...92,750,164
Ensembl chr 9:92,507,611...92,750,164
|
|
G |
Hif1a |
hypoxia inducible factor 1 subunit alpha |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HIF1A mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 6:92,624,059...92,669,262
Ensembl chr 6:92,624,390...92,669,261
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCR mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HMGCS1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HMOX1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hp1bp3 |
heterochromatin protein 1, binding protein 3 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HP1BP3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HP1BP3 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:150,435,781...150,463,004
Ensembl chr 5:150,433,740...150,463,000
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSD17B3 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of HSD17B3 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of HSD3B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of HSD3B1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsf2 |
heat shock transcription factor 2 |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of HSF2 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of HSF2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of HSF2 mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr20:36,819,864...36,847,490
Ensembl chr20:36,819,864...36,850,174
|
|
G |
Il1b |
interleukin 1 beta |
increases expression |
ISO |
Allethrins results in increased expression of IL1B mRNA |
CTD |
PMID:24055895 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Inhba |
inhibin subunit beta A |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of INHBA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of INHBA mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr17:49,091,635...49,111,573
Ensembl chr17:49,095,920...49,108,982
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Kdm3a |
lysine demethylase 3A |
decreases expression |
EXP |
Allethrins results in decreased expression of KDM3A mRNA |
CTD |
PMID:28181402 |
|
NCBI chr 4:103,630,907...103,675,073
Ensembl chr 4:103,630,908...103,675,073
|
|
G |
Kit |
KIT proto-oncogene receptor tyrosine kinase |
decreases expression |
EXP |
Allethrins results in decreased expression of KIT mRNA |
CTD |
PMID:28181402 |
|
NCBI chr14:32,547,459...32,624,694
Ensembl chr14:32,548,877...32,624,652
|
|
G |
Kitlg |
KIT ligand |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of KITLG mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of KITLG mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of KITLG mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr 7:34,896,075...34,977,215
Ensembl chr 7:34,896,053...34,977,214
|
|
G |
Klf4 |
KLF transcription factor 4 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of KLF4 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 5:70,278,843...70,283,751
Ensembl chr 5:70,278,972...70,283,602
|
|
G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of LHCGR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of LHCGR mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 6:5,661,871...5,728,109
Ensembl chr 6:5,661,871...5,724,521
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases expression |
EXP |
Allethrins results in increased expression of MAPK1 protein modified form |
CTD |
PMID:23595975 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases expression |
EXP |
Allethrins results in increased expression of MAPK3 protein modified form |
CTD |
PMID:23595975 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mmp9 |
matrix metallopeptidase 9 |
increases expression |
ISO |
Allethrins results in increased expression of MMP9 protein |
CTD |
PMID:24055895 |
|
NCBI chr 3:153,684,158...153,692,118
Ensembl chr 3:153,683,858...153,692,120
|
|
G |
Mtf1 |
metal-regulatory transcription factor 1 |
increases activity |
ISO |
Allethrins results in increased activity of MTF1 protein |
CTD |
PMID:20143881 |
|
NCBI chr 5:137,062,319...137,107,136
Ensembl chr 5:137,062,376...137,107,136
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
increases activity |
ISO |
Allethrins results in increased activity of MYC protein |
CTD |
PMID:20143881 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ncoa7 |
nuclear receptor coactivator 7 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NCOA7 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NCOA7 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 1:26,856,228...27,016,950
Ensembl chr 1:26,856,530...27,015,871
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NFE2L2 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of NQO1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr0b1 |
nuclear receptor subfamily 0, group B, member 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of NR0B1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of NR0B1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr X:50,756,886...50,761,014
Ensembl chr X:50,756,886...50,761,011
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
EXP |
Allethrins binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:31538121 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
Allethrins results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr5a1 |
nuclear receptor subfamily 5, group A, member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of NR5A1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 3:22,464,786...22,486,328
Ensembl chr 3:22,465,502...22,486,328
|
|
G |
Ovol1 |
ovo like transcriptional repressor 1 |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of OVOL1 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of OVOL1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of OVOL1 mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr 1:202,855,261...202,868,858
Ensembl chr 1:202,855,265...202,866,831
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
multiple interactions |
EXP |
Allethrins results in decreased expression of and results in increased cleavage of PARP1 protein |
CTD |
PMID:25072698 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Pcna |
proliferating cell nuclear antigen |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of PCNA mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PCNA mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Pde4b |
phosphodiesterase 4B |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PDE4B mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PDE4B mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:116,799,827...117,367,707
Ensembl chr 5:116,799,971...117,367,696
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity increases expression |
ISO |
Allethrins results in increased activity of PPARG protein Allethrins results in increased expression of PPARG mRNA |
CTD |
PMID:20143881 PMID:32473317 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Prm1 |
protamine 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PRM1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of PRM1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr10:4,871,909...4,872,155
|
|
G |
Prm2 |
protamine 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PRM2 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr10:4,876,398...4,876,834
Ensembl chr10:4,873,372...4,877,026
|
|
G |
Pygo2 |
pygopus family PHD finger 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of PYGO2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of PYGO2 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 2:174,849,670...174,854,758
Ensembl chr 2:174,849,936...174,854,758
|
|
G |
Rara |
retinoic acid receptor, alpha |
increases activity |
ISO |
Allethrins results in increased activity of RARA protein |
CTD |
PMID:20143881 |
|
NCBI chr10:83,883,490...83,928,932
Ensembl chr10:83,893,384...83,928,142
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SCARB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SCARB1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
multiple interactions |
EXP |
Allethrins affects the reaction [SCN10A protein results in increased transport of Sodium] |
CTD |
PMID:16051293 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Sirt1 |
sirtuin 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of SIRT1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of SIRT1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr20:25,307,143...25,329,260
Ensembl chr20:25,306,917...25,329,260
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of SOX9 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of SOX9 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Sp1 |
Sp1 transcription factor |
increases activity |
ISO |
Allethrins results in increased activity of SP1 protein |
CTD |
PMID:20143881 |
|
NCBI chr 7:133,541,302...133,571,961
Ensembl chr 7:133,541,491...133,571,961
|
|
G |
Sp7 |
Sp7 transcription factor |
multiple interactions |
ISO |
Allethrins inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
|
|
G |
Spag11bl |
sperm associated antigen 11b-like |
decreases expression |
EXP |
Allethrins results in decreased expression of SPAG11A mRNA |
CTD |
PMID:23595975 |
|
NCBI chr16:70,697,810...70,700,336
Ensembl chr16:70,698,127...70,700,110
|
|
G |
Star |
steroidogenic acute regulatory protein |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of STAR mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of STAR mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of STAR mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Tet1 |
tet methylcytosine dioxygenase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TET1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TET1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr20:25,761,042...25,840,926
Ensembl chr20:25,768,120...25,833,052
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of TGFB1 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TGFB1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TGFB1 mRNA |
CTD |
PMID:23595975 PMID:33051911 PMID:33396045 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Thy1 |
Thy-1 cell surface antigen |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of THY1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of THY1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:44,389,495...44,394,688
Ensembl chr 8:44,389,513...44,394,659
|
|
G |
Tnf |
tumor necrosis factor |
increases expression |
ISO |
Allethrins results in increased expression of TNF mRNA |
CTD |
PMID:24055895 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tnp1 |
transition protein 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of TNP1 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 9:74,594,463...74,595,072
Ensembl chr 9:74,594,466...74,595,274
|
|
G |
Tnp2 |
transition protein 2 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TNP2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TNP2 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr10:4,879,812...4,880,540
Ensembl chr10:4,879,812...4,880,538
|
|
G |
Tp53 |
tumor protein p53 |
affects expression decreases expression increases expression |
EXP |
Allethrins affects the expression of TP53 protein Allethrins results in decreased expression of TP53 mRNA Allethrins results in increased expression of TP53 mRNA |
CTD |
PMID:22356257 PMID:23595975 PMID:25072698 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of DNMT2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of TRDMT1 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439
|
|
G |
Trpm2 |
transient receptor potential cation channel, subfamily M, member 2 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TRPM2 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr20:10,703,568...10,753,189
Ensembl chr20:10,707,014...10,753,181
|
|
G |
Tspo |
translocator protein |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of TSPO mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of TSPO mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
G |
Vim |
vimentin |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of VIM mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of VIM mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr17:76,668,701...76,677,186
Ensembl chr17:76,668,647...76,677,187
|
|
G |
Wnt1 |
Wnt family member 1 |
multiple interactions |
EXP |
[cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in decreased expression of WNT1 mRNA |
CTD |
PMID:33396045 |
|
NCBI chr 7:129,938,604...129,942,651
Ensembl chr 7:129,938,604...129,942,651
|
|
G |
Wnt10b |
Wnt family member 10B |
increases expression |
ISO |
Allethrins results in increased expression of WNT10B mRNA |
CTD |
PMID:12437293 |
|
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892
|
|
G |
Wnt4 |
Wnt family member 4 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in increased expression of WNT4 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of WNT4 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 5:149,513,573...149,535,415
Ensembl chr 5:149,514,018...149,532,859
|
|
G |
Ybx2 |
Y box binding protein 2 |
decreases expression multiple interactions |
EXP |
Allethrins results in decreased expression of YBX2 mRNA [Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] results in decreased expression of YBX2 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] affects the expression of YBX2 mRNA |
CTD |
PMID:28181402 PMID:33051911 PMID:33396045 |
|
NCBI chr10:54,659,719...54,665,371
Ensembl chr10:54,659,719...54,665,371
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
multiple interactions |
EXP |
[Allethrins co-treated with cyhalothrin co-treated with cypermethrin co-treated with decamethrin co-treated with fenvalerate] affects the expression of ZBTB16 mRNA; [cypermethrin co-treated with decamethrin co-treated with fenvalerate co-treated with cyhalothrin co-treated with Allethrins] results in increased expression of ZBTB16 mRNA |
CTD |
PMID:33051911 PMID:33396045 |
|
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
|
|
|
G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
increases expression |
ISO |
bifenthrin results in increased expression of ABCB1B mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 4:25,242,761...25,325,194
Ensembl chr 4:25,242,798...25,325,199
|
|
G |
Ache |
acetylcholinesterase |
multiple interactions decreases expression |
EXP |
bifenthrin results in decreased expression of and results in decreased activity of ACHE protein bifenthrin results in decreased expression of ACHE mRNA; bifenthrin results in decreased expression of ACHE protein |
CTD |
PMID:29775722 PMID:30978409 |
|
NCBI chr12:19,407,359...19,413,713
Ensembl chr12:19,407,360...19,413,651
|
|
G |
Adh1 |
alcohol dehydrogenase 1C (class I), gamma polypeptide |
increases expression |
ISO |
bifenthrin results in increased expression of ADH1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:226,797,303...226,808,892
Ensembl chr 2:226,797,303...226,808,892
|
|
G |
Adh5 |
alcohol dehydrogenase 5 (class III), chi polypeptide |
increases expression |
ISO |
bifenthrin results in increased expression of ADH5 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:226,975,184...226,987,591
Ensembl chr 2:226,947,466...226,987,591
|
|
G |
Ahr |
aryl hydrocarbon receptor |
increases expression |
ISO |
bifenthrin results in increased expression of AHR mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aldh1a1 |
aldehyde dehydrogenase 1 family, member A1 |
increases expression |
ISO |
bifenthrin results in increased expression of ALDH1A1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 1:218,000,470...218,152,962
Ensembl chr 1:218,042,127...218,152,961
|
|
G |
Alox12 |
arachidonate 12-lipoxygenase, 12S type |
decreases expression |
ISO |
bifenthrin results in decreased expression of ALOX12 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr10:54,958,263...54,970,542
Ensembl chr10:54,958,271...54,970,542
|
|
G |
Alox15 |
arachidonate 15-lipoxygenase |
increases expression |
ISO |
bifenthrin results in increased expression of ALOX15 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr10:55,060,169...55,068,885
Ensembl chr10:55,060,412...55,068,874
|
|
G |
Alpl |
alkaline phosphatase, biomineralization associated |
multiple interactions |
ISO |
bifenthrin inhibits the reaction [Aldosterone results in increased expression of ALPL mRNA] |
CTD |
PMID:29149346 |
|
NCBI chr 5:149,951,397...150,006,424
Ensembl chr 5:149,951,409...150,006,446
|
|
G |
Apaf1 |
apoptotic peptidase activating factor 1 |
increases expression |
ISO |
bifenthrin results in increased expression of APAF1 mRNA |
CTD |
PMID:26071804 PMID:32408700 |
|
NCBI chr 7:25,494,143...25,579,540
Ensembl chr 7:25,494,609...25,579,540
|
|
G |
Apoe |
apolipoprotein E |
increases expression |
ISO |
bifenthrin results in increased expression of APOE mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 1:79,353,924...79,357,852
Ensembl chr 1:79,353,916...79,357,932
|
|
G |
Areg |
amphiregulin |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of AREG mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr14:16,972,185...16,981,443
Ensembl chr14:16,972,187...16,981,535
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
increases expression |
ISO |
bifenthrin results in increased expression of ARNT mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
increases expression |
ISO |
bifenthrin results in increased expression of BAX mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bche |
butyrylcholinesterase |
decreases activity |
EXP |
bifenthrin results in decreased activity of BCHE protein |
CTD |
PMID:30978409 |
|
NCBI chr 2:158,308,674...158,401,148
Ensembl chr 2:158,307,584...158,401,148
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
decreases expression |
ISO |
bifenthrin results in decreased expression of BCL2 mRNA |
CTD |
PMID:26071804 PMID:27916261 PMID:32408700 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bid |
BH3 interacting domain death agonist |
increases expression |
ISO |
bifenthrin results in increased expression of BID mRNA |
CTD |
PMID:26071804 PMID:32408700 |
|
NCBI chr 4:154,113,198...154,136,353
Ensembl chr 4:154,113,198...154,134,720
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
affects binding |
ISO |
bifenthrin binds to BRCA1 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression |
ISO EXP |
bifenthrin results in increased activity of CASP3 protein bifenthrin results in increased expression of CASP3 protein bifenthrin results in increased expression of CASP3 mRNA |
CTD |
PMID:26071804 PMID:27916261 PMID:30978409 PMID:32408700 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp8 |
caspase 8 |
increases activity decreases expression |
ISO |
bifenthrin results in increased activity of CASP8 protein bifenthrin results in decreased expression of CASP8 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
bifenthrin results in increased expression of CASP9 mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
multiple interactions decreases activity decreases expression increases expression affects activity |
ISO EXP |
Quercetin inhibits the reaction [bifenthrin results in decreased activity of CAT protein]; Rutin inhibits the reaction [bifenthrin results in decreased activity of CAT protein] bifenthrin results in decreased expression of CAT protein bifenthrin analog results in increased expression of CAT mRNA; bifenthrin results in increased expression of CAT mRNA bifenthrin affects the activity of CAT protein; bifenthrin analog affects the activity of CAT protein |
CTD |
PMID:19833193 PMID:23172818 PMID:25149237 PMID:27916261 PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 PMID:32408700 More...
|
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Ccne1 |
cyclin E1 |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of CCNE1 mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cd36 |
CD36 molecule |
increases expression |
ISO |
bifenthrin results in increased expression of CD36 mRNA |
CTD |
PMID:29554630 |
|
NCBI chr 4:17,317,343...17,410,084
Ensembl chr 4:17,354,466...17,513,903
|
|
G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr20:7,149,177...7,159,727
Ensembl chr20:7,149,217...7,159,585
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of CEBPB mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Ces2e |
carboxylesterase 2E |
affects metabolic processing |
ISO |
CES2E protein affects the metabolism of bifenthrin |
CTD |
PMID:15123619 |
|
NCBI chr19:157,447...172,822
Ensembl chr19:157,407...172,856
|
|
G |
Ces2h |
carboxylesterase 2H |
increases metabolic processing |
ISO |
CES2 protein results in increased metabolism of bifenthrin |
CTD |
PMID:19249324 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cga |
glycoprotein hormones, alpha polypeptide |
multiple interactions increases secretion |
EXP ISO |
bifenthrin analog inhibits the reaction [CGA protein results in increased abundance of Progesterone]; bifenthrin analog inhibits the reaction [CGA protein results in increased secretion of Dinoprostone]; bifenthrin analog inhibits the reaction [CGA results in increased expression of CYP11A1 mRNA]; bifenthrin analog inhibits the reaction [CGA results in increased expression of DBI mRNA]; bifenthrin analog inhibits the reaction [CGA results in increased expression of PTGS2 mRNA]; bifenthrin analog inhibits the reaction [CGA results in increased expression of STAR mRNA]; bifenthrin analog inhibits the reaction [CGA results in increased expression of TSPO mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of AREG mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CCNE1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CDKN1A mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CEBPB mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP11A1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of EREG mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of PGR mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of RUNX1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of STAR mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of SULT1E1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of TGFB1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased secretion of Dinoprostone] fulvestrant inhibits the reaction [bifenthrin results in increased secretion of CGA protein] |
CTD |
PMID:21251947 PMID:21871944 PMID:24938463 |
|
NCBI chr 5:49,486,915...49,499,192
Ensembl chr 5:49,487,068...49,499,191
|
|
G |
Chat |
choline O-acetyltransferase |
decreases expression |
EXP |
bifenthrin results in decreased expression of CHAT mRNA |
CTD |
PMID:29775722 |
|
NCBI chr16:7,657,362...7,717,093
Ensembl chr16:7,657,362...7,717,093
|
|
G |
Chrm1 |
cholinergic receptor, muscarinic 1 |
decreases expression |
EXP |
bifenthrin results in decreased expression of CHRM1 mRNA |
CTD |
PMID:29775722 PMID:30978409 |
|
NCBI chr 1:205,567,046...205,583,001
Ensembl chr 1:205,567,220...205,582,356
|
|
G |
Chrna2 |
cholinergic receptor nicotinic alpha 2 subunit |
decreases expression |
EXP |
bifenthrin results in decreased expression of CHRNA2 mRNA |
CTD |
PMID:30978409 |
|
NCBI chr15:40,342,317...40,358,601
Ensembl chr15:40,342,317...40,358,601
|
|
G |
Cpt1a |
carnitine palmitoyltransferase 1A |
decreases expression |
ISO |
bifenthrin results in decreased expression of CPT1A mRNA |
CTD |
PMID:29554630 |
|
NCBI chr 1:200,564,634...200,627,059
Ensembl chr 1:200,565,613...200,627,055
|
|
G |
Cxcl3 |
C-X-C motif chemokine ligand 3 |
decreases expression |
ISO |
bifenthrin results in decreased expression of CXCL1 mRNA |
CTD |
PMID:28251819 |
|
NCBI chr14:17,270,146...17,289,458
Ensembl chr14:17,270,146...17,289,511
|
|
G |
Cyb5r3 |
cytochrome b5 reductase 3 |
increases expression |
ISO |
bifenthrin results in increased expression of CYB5R3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 7:114,306,686...114,324,247
Ensembl chr 7:114,306,685...114,324,298
|
|
G |
Cycs |
cytochrome c, somatic |
increases expression |
ISO |
bifenthrin results in increased expression of CYCS mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 4:79,651,894...79,653,994
Ensembl chr 4:79,651,378...79,654,054
|
|
G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
multiple interactions decreases expression |
EXP ISO |
bifenthrin analog inhibits the reaction [CGA results in increased expression of CYP11A1 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP11A1 mRNA] bifenthrin results in decreased expression of CYP11A1 mRNA |
CTD |
PMID:21251947 PMID:21871944 PMID:23994515 PMID:24449165 PMID:32408700 |
|
NCBI chr 8:58,422,807...58,434,342
Ensembl chr 8:58,404,669...58,434,338
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression decreases expression |
ISO |
bifenthrin results in increased expression of CYP17A1 mRNA bifenthrin results in decreased expression of CYP17A1 mRNA |
CTD |
PMID:23994515 PMID:24449165 PMID:24938463 PMID:26071804 PMID:32408700 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
multiple interactions increases expression |
EXP ISO |
bifenthrin inhibits the reaction [CGA protein results in increased expression of CYP19A1 mRNA] bifenthrin results in increased expression of CYP19A1 mRNA |
CTD |
PMID:21251947 PMID:24938463 |
|
NCBI chr 8:54,553,165...54,580,758
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
increases activity decreases expression |
EXP ISO |
bifenthrin results in increased activity of CYP1A1 protein bifenthrin results in decreased expression of CYP1A1 mRNA |
CTD |
PMID:20009351 PMID:26071804 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2c79 |
cytochrome P450, family 2, subfamily c, polypeptide 79 |
increases expression |
ISO |
bifenthrin results in increased expression of CYP2C29 mRNA |
CTD |
PMID:26071804 |
|
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
increases expression |
ISO |
bifenthrin results in increased expression of CYP2E1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
bifenthrin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:19249324 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp4b1 |
cytochrome P450, family 4, subfamily b, polypeptide 1 |
decreases expression |
ISO |
bifenthrin results in decreased expression of CYP4B1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 5:129,139,019...129,176,860
Ensembl chr 5:129,139,038...129,156,348
|
|
G |
Dbi |
diazepam binding inhibitor |
multiple interactions |
EXP |
bifenthrin analog inhibits the reaction [CGA results in increased expression of DBI mRNA] |
CTD |
PMID:21871944 |
|
NCBI chr13:31,241,466...31,249,853
Ensembl chr13:31,206,988...31,268,693
|
|
G |
Ephx1 |
epoxide hydrolase 1 |
increases expression |
ISO |
bifenthrin results in increased expression of EPHX1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr13:92,714,315...92,744,124
Ensembl chr13:92,714,315...92,790,235
|
|
G |
Erbb2 |
erb-b2 receptor tyrosine kinase 2 |
affects binding |
ISO |
bifenthrin binds to ERBB2 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:83,411,197...83,435,078
Ensembl chr10:83,411,313...83,435,078
|
|
G |
Ereg |
epiregulin |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of EREG mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr14:17,027,287...17,041,062
Ensembl chr14:17,027,287...17,041,062
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression multiple interactions affects binding |
ISO |
bifenthrin results in decreased expression of ESR1 mRNA bifenthrin binds to and results in increased activity of ESR1 protein bifenthrin binds to ESR1 protein |
CTD |
PMID:20097460 PMID:32278787 PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
bifenthrin binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Faim |
Fas apoptotic inhibitory molecule |
decreases expression |
ISO |
bifenthrin results in decreased expression of FAIM mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 8:99,543,877...99,569,499
Ensembl chr 8:99,542,405...99,560,562
|
|
G |
Faslg |
Fas ligand |
decreases expression |
ISO |
bifenthrin results in decreased expression of FASL mRNA |
CTD |
PMID:26071804 |
|
NCBI chr13:74,151,519...74,172,760
Ensembl chr13:74,154,954...74,162,215
|
|
G |
Fasn |
fatty acid synthase |
increases expression decreases expression |
ISO |
bifenthrin results in increased expression of FASN mRNA bifenthrin results in decreased expression of FASN mRNA |
CTD |
PMID:29554630 PMID:32408700 |
|
NCBI chr10:106,072,093...106,090,259
Ensembl chr10:106,072,091...106,090,261
|
|
G |
Fbp1 |
fructose-bisphosphatase 1 |
increases expression |
ISO |
bifenthrin results in increased expression of FBP1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr17:2,207,271...2,230,076
Ensembl chr17:2,208,031...2,230,071
|
|
G |
Fgfr2 |
fibroblast growth factor receptor 2 |
affects binding |
ISO |
bifenthrin binds to FGFR2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 1:184,745,418...184,850,655
Ensembl chr 1:184,745,420...184,850,626
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
increases expression |
ISO |
bifenthrin results in increased expression of GGT1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Gnrh1 |
gonadotropin releasing hormone 1 |
increases expression |
ISO |
bifenthrin results in increased expression of GNRH1 mRNA |
CTD |
PMID:24938463 |
|
NCBI chr15:41,972,482...41,976,690
Ensembl chr15:41,972,905...41,973,581 Ensembl chr15:41,972,905...41,973,581
|
|
G |
Gnrhr |
gonadotropin releasing hormone receptor |
increases expression |
ISO |
bifenthrin results in increased expression of GNRHR mRNA |
CTD |
PMID:24938463 |
|
NCBI chr14:21,856,871...21,874,861
Ensembl chr14:21,856,871...21,874,861
|
|
G |
Gpi |
glucose-6-phosphate isomerase |
increases expression |
ISO |
bifenthrin results in increased expression of GPI1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 1:86,828,211...86,856,077
Ensembl chr 1:86,828,216...86,856,086
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
increases expression decreases expression |
ISO |
bifenthrin results in increased expression of GPX1 mRNA bifenthrin results in decreased expression of GPX1 mRNA |
CTD |
PMID:26071804 PMID:27916261 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Gpx2 |
glutathione peroxidase 2 |
increases expression decreases expression |
ISO |
bifenthrin results in increased expression of GPX2 mRNA bifenthrin results in decreased expression of GPX2 mRNA |
CTD |
PMID:26071804 PMID:27916261 |
|
NCBI chr 6:95,493,589...95,496,877
Ensembl chr 6:95,493,589...95,496,877
|
|
G |
Gpx3 |
glutathione peroxidase 3 |
increases expression |
ISO |
bifenthrin results in increased expression of GPX3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr10:39,028,624...39,036,695
Ensembl chr10:39,028,570...39,037,035
|
|
G |
Gsta2 |
glutathione S-transferase alpha 2 |
increases expression |
ISO |
bifenthrin results in increased expression of GSTA1 mRNA |
CTD |
PMID:26071804 PMID:27916261 |
|
NCBI chr 8:79,184,535...79,196,827
Ensembl chr 8:79,184,322...79,196,798
|
|
G |
Gstm1 |
glutathione S-transferase mu 1 |
increases expression |
ISO |
bifenthrin results in increased expression of GSTM1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:195,649,845...195,655,402
Ensembl chr 2:195,649,845...195,655,411
|
|
G |
Gstm2 |
glutathione S-transferase mu 2 |
increases expression |
ISO |
bifenthrin results in increased expression of GSTM2 mRNA; bifenthrin results in increased expression of GSTM5 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:195,624,015...195,628,774
Ensembl chr 2:195,544,426...195,628,961
|
|
G |
Gstp1 |
glutathione S-transferase pi 1 |
increases expression |
ISO |
bifenthrin results in increased expression of GSTP1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 1:201,337,762...201,340,230
Ensembl chr 1:201,321,672...201,340,226
|
|
G |
Hk2 |
hexokinase 2 |
increases expression |
ISO |
bifenthrin results in increased expression of HK2 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 4:115,234,509...115,283,530
Ensembl chr 4:115,234,509...115,283,530
|
|
G |
Hmox1 |
heme oxygenase 1 |
increases expression |
ISO |
bifenthrin analog results in increased expression of HMOX1 mRNA; bifenthrin results in increased expression of HMOX1 mRNA |
CTD |
PMID:25149237 PMID:27916261 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSD17B1 mRNA |
CTD |
PMID:24938463 |
|
NCBI chr10:86,009,728...86,011,928
Ensembl chr10:86,009,728...86,011,927
|
|
G |
Hsd17b3 |
hydroxysteroid (17-beta) dehydrogenase 3 |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSD17B3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr17:1,027,229...1,058,554
Ensembl chr17:1,027,229...1,058,554
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSD3B1 mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Hsd3b2 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 |
increases expression |
ISO |
bifenthrin results in increased expression of HSD3B2 mRNA |
CTD |
PMID:24938463 |
|
NCBI chr 2:186,095,897...186,105,354
Ensembl chr 2:186,095,897...186,101,852
|
|
G |
Hspa1b |
heat shock protein family A (Hsp70) member 1B |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSPA1A protein |
CTD |
PMID:16271832 |
|
NCBI chr20:3,870,765...3,873,221
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression |
ISO |
bifenthrin results in increased expression of HSPA5 protein |
CTD |
PMID:16271832 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Hspa8 |
heat shock protein family A (Hsp70) member 8 |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSPA8 protein |
CTD |
PMID:16271832 |
|
NCBI chr 8:41,183,397...41,187,260
Ensembl chr 8:41,183,264...41,187,259
|
|
G |
Hspb2 |
heat shock protein family B (small) member 2 |
decreases expression |
ISO |
bifenthrin results in decreased expression of HSPB2 protein |
CTD |
PMID:16271832 |
|
NCBI chr 8:51,093,267...51,094,864
Ensembl chr 8:51,081,342...51,094,533
|
|
G |
Il1b |
interleukin 1 beta |
decreases expression increases expression multiple interactions |
ISO EXP |
bifenthrin results in decreased expression of IL1B mRNA bifenthrin results in increased expression of IL1B mRNA bifenthrin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL1B mRNA] |
CTD |
PMID:27916261 PMID:28251819 PMID:30102949 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
increases expression |
ISO |
bifenthrin results in increased expression of IL2 mRNA |
CTD |
PMID:23172818 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Il4 |
interleukin 4 |
increases expression |
ISO |
bifenthrin results in increased expression of IL4 mRNA |
CTD |
PMID:23172818 |
|
NCBI chr10:37,771,203...37,776,750
Ensembl chr10:37,771,203...37,776,750
|
|
G |
Il6 |
interleukin 6 |
decreases expression increases expression multiple interactions |
ISO EXP |
bifenthrin results in decreased expression of IL6 mRNA bifenthrin results in increased expression of IL6 protein bifenthrin results in increased expression of IL6 mRNA bifenthrin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of IL6 mRNA] |
CTD |
PMID:27916261 PMID:28251819 PMID:29793499 PMID:30102949 PMID:32061760 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Ldlr |
low density lipoprotein receptor |
decreases expression |
ISO |
bifenthrin results in decreased expression of LDLR mRNA |
CTD |
PMID:24449165 PMID:32408700 |
|
NCBI chr 8:20,270,020...20,292,981
Ensembl chr 8:20,270,041...20,294,580
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
bifenthrin analog results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:19442700 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
bifenthrin analog results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:19442700 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Mgst2 |
microsomal glutathione S-transferase 2 |
decreases expression |
ISO |
bifenthrin results in decreased expression of MGST2 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:135,679,524...135,715,828
Ensembl chr 2:135,693,557...135,715,828
|
|
G |
Mgst3 |
microsomal glutathione S-transferase 3 |
increases expression |
ISO |
bifenthrin results in increased expression of MGST3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr13:79,526,541...79,547,479
Ensembl chr13:79,526,541...79,547,411
|
|
G |
Mir122 |
microRNA 122 |
increases expression |
ISO |
bifenthrin results in increased expression of MIR122 mRNA |
CTD |
PMID:32408700 |
|
NCBI chr18:58,758,703...58,758,787
|
|
G |
Mir17 |
microRNA 17 |
decreases expression |
ISO |
bifenthrin results in decreased expression of MIR17 mRNA |
CTD |
PMID:32408700 |
|
NCBI chr15:92,180,629...92,180,712
Ensembl chr15:92,180,629...92,180,712
|
|
G |
Mir34b |
microRNA 34b |
decreases expression |
ISO |
bifenthrin results in decreased expression of MIR34B mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 8:51,410,244...51,410,327
Ensembl chr 8:51,410,244...51,410,327
|
|
G |
Mir34c |
microRNA 34c |
decreases expression |
ISO |
bifenthrin results in decreased expression of MIR34C mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 8:51,409,726...51,409,802
Ensembl chr 8:51,409,726...51,409,802
|
|
G |
Mir449a |
microRNA 449a |
decreases expression |
ISO |
bifenthrin results in decreased expression of MIR449A mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 2:44,670,714...44,670,804
Ensembl chr 2:44,670,714...44,670,804
|
|
G |
Mir449c |
microRNA 449c |
decreases expression |
ISO |
bifenthrin results in decreased expression of MIR449C mRNA |
CTD |
PMID:32408700 |
|
NCBI chr 2:44,669,179...44,669,277
Ensembl chr 2:44,669,179...44,669,277
|
|
G |
Mt2A |
metallothionein 2A |
increases expression |
ISO |
bifenthrin results in increased expression of MT2 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr19:10,832,009...10,832,783
Ensembl chr19:10,832,002...10,832,784
|
|
G |
Mt3 |
metallothionein 3 |
increases expression |
ISO |
bifenthrin results in increased expression of MT3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr19:10,848,754...10,850,158
Ensembl chr19:10,848,755...10,850,158
|
|
G |
Mthfr |
methylenetetrahydrofolate reductase |
increases expression |
ISO |
bifenthrin results in increased expression of MTHFR mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 5:158,465,248...158,484,999
Ensembl chr 5:158,465,296...158,483,797
|
|
G |
Nat1 |
N-acetyltransferase 1 |
increases expression |
ISO |
bifenthrin results in increased expression of NAT1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr16:22,218,217...22,238,516
Ensembl chr16:22,208,194...22,238,520
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
decreases expression increases expression |
EXP ISO |
bifenthrin results in decreased expression of NFE2L2 mRNA; bifenthrin results in decreased expression of NFE2L2 protein bifenthrin results in increased expression of NFE2L2 mRNA; bifenthrin results in increased expression of NFE2L2 protein |
CTD |
PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
decreases expression affects binding |
ISO |
bifenthrin results in decreased expression of NQO1 mRNA bifenthrin binds to NQO1 protein |
CTD |
PMID:27916261 PMID:32278787 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
bifenthrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions increases expression affects binding |
ISO EXP |
bifenthrin results in increased activity of NR1I2 protein bifenthrin binds to and results in increased activity of NR1I2 protein bifenthrin results in increased expression of NR1I2 mRNA; bifenthrin results in increased expression of NR1I2 protein bifenthrin binds to NR1I2 protein |
CTD |
PMID:19249324 PMID:29554630 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
bifenthrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:26647222 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
multiple interactions |
ISO |
bifenthrin inhibits the reaction [Aldosterone affects the localization of NR3C2 protein]; bifenthrin inhibits the reaction [Aldosterone results in increased activity of NR3C2 protein] |
CTD |
PMID:29149346 |
|
NCBI chr19:30,715,648...31,059,885
Ensembl chr19:30,715,648...31,059,885
|
|
G |
Nr4a2 |
nuclear receptor subfamily 4, group A, member 2 |
decreases expression |
EXP |
bifenthrin results in decreased expression of NR4A2 mRNA; bifenthrin results in decreased expression of NR4A2 protein |
CTD |
PMID:30978409 |
|
NCBI chr 3:41,689,847...41,707,036
Ensembl chr 3:41,689,851...41,697,877
|
|
G |
Pck1 |
phosphoenolpyruvate carboxykinase 1 |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [Hydrocortisone results in increased expression of PCK1 mRNA] |
CTD |
PMID:26647222 |
|
NCBI chr 3:161,930,256...161,936,205
Ensembl chr 3:161,930,256...161,936,191
|
|
G |
Pgr |
progesterone receptor |
multiple interactions increases expression |
EXP ISO |
bifenthrin inhibits the reaction [CGA protein results in increased expression of PGR mRNA] fulvestrant inhibits the reaction [bifenthrin results in increased expression of PGR mRNA] bifenthrin results in increased expression of PGR; bifenthrin results in increased expression of PGR mRNA |
CTD |
PMID:21251947 PMID:24938463 |
|
NCBI chr 8:6,073,216...6,131,552
Ensembl chr 8:6,072,673...6,131,344
|
|
G |
Pklr |
pyruvate kinase L/R |
decreases expression |
ISO |
bifenthrin results in decreased expression of PKLR mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 2:174,543,008...174,551,863
Ensembl chr 2:174,543,039...174,551,870
|
|
G |
Pkm |
pyruvate kinase M1/2 |
increases expression |
ISO |
bifenthrin results in increased expression of PKM mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 8:60,057,629...60,079,600
Ensembl chr 8:60,057,402...60,079,599
|
|
G |
Pon1 |
paraoxonase 1 |
increases expression |
ISO |
bifenthrin results in increased expression of PON1 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 4:33,294,737...33,325,759
Ensembl chr 4:33,294,722...33,321,360
|
|
G |
Pon3 |
paraoxonase 3 |
increases expression |
ISO |
bifenthrin results in increased expression of PON3 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 4:33,356,983...33,383,681
Ensembl chr 4:33,349,168...33,383,855
|
|
G |
Ppard |
peroxisome proliferator-activated receptor delta |
affects binding |
ISO |
bifenthrin binds to PPARD protein |
CTD |
PMID:32278787 |
|
NCBI chr20:6,298,785...6,363,970
Ensembl chr20:6,298,785...6,363,968
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
bifenthrin results in increased expression of PPARG mRNA bifenthrin binds to and results in increased activity of PPARG protein |
CTD |
PMID:29554630 PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Ptges |
prostaglandin E synthase |
increases expression |
EXP ISO |
bifenthrin results in increased expression of PTGES mRNA; bifenthrin results in increased expression of PTGES protein |
CTD |
PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 |
|
NCBI chr 3:14,177,892...14,189,236
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions increases expression |
EXP ISO |
bifenthrin analog inhibits the reaction [CGA results in increased expression of PTGS2 mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of PTGS2 mRNA]; bifenthrin inhibits the reaction [Colforsin results in increased expression of PTGS2 mRNA] bifenthrin results in increased expression of PTGS2 mRNA; bifenthrin results in increased expression of PTGS2 protein |
CTD |
PMID:21251947 PMID:21871944 PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 More...
|
|
NCBI chr13:62,164,080...62,169,770
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Rela |
RELA proto-oncogene, NF-kB subunit |
increases expression |
EXP ISO |
bifenthrin results in increased expression of RELA mRNA; bifenthrin results in increased expression of RELA protein |
CTD |
PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 |
|
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
|
|
G |
Rora |
RAR-related orphan receptor A |
affects binding |
ISO |
bifenthrin binds to RORA protein |
CTD |
PMID:32278787 |
|
NCBI chr 8:69,301,635...70,034,741
Ensembl chr 8:69,301,733...70,025,931
|
|
G |
Rorc |
RAR-related orphan receptor C |
affects binding |
ISO |
bifenthrin binds to RORC protein |
CTD |
PMID:32278787 |
|
NCBI chr 2:182,009,707...182,034,910
Ensembl chr 2:182,009,286...182,034,907
|
|
G |
RT1-M3-1 |
RT1 class Ib, locus M3, gene 1 |
multiple interactions increases expression |
ISO |
Fulvestrant inhibits the reaction [bifenthrin results in increased expression of HLA-G mRNA] |
CTD |
PMID:24938463 |
|
NCBI chr20:1,323,976...1,328,126
Ensembl chr20:1,287,521...1,328,117
|
|
G |
Runx1 |
RUNX family transcription factor 1 |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of RUNX1 mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr11:31,839,880...32,074,427
Ensembl chr11:31,843,764...32,074,542
|
|
G |
Scarb1 |
scavenger receptor class B, member 1 |
decreases expression |
ISO |
bifenthrin results in decreased expression of SCARB1 mRNA |
CTD |
PMID:23994515 |
|
NCBI chr12:31,296,143...31,362,649
Ensembl chr12:31,296,156...31,362,647
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
ISO |
bifenthrin results in increased expression of SCD mRNA |
CTD |
PMID:29554630 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scn10a |
sodium voltage-gated channel alpha subunit 10 |
multiple interactions |
EXP |
bifenthrin affects the reaction [SCN10A protein results in increased transport of Sodium] |
CTD |
PMID:16051293 |
|
NCBI chr 8:119,350,723...119,462,882
Ensembl chr 8:119,350,724...119,462,614
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
bifenthrin binds to SHBG protein |
CTD |
PMID:32278787 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|
G |
Sod1 |
superoxide dismutase 1 |
multiple interactions increases expression |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bifenthrin analog results in increased expression of SOD1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [bifenthrin analog results in increased expression of SOD1 protein] bifenthrin analog results in increased expression of SOD1 mRNA; bifenthrin results in increased expression of SOD1 mRNA |
CTD |
PMID:22718203 PMID:25149237 PMID:27916261 |
|
NCBI chr11:29,456,673...29,462,249
Ensembl chr11:29,456,558...29,462,249
|
|
G |
Sod2 |
superoxide dismutase 2 |
multiple interactions increases expression |
EXP ISO |
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [bifenthrin analog results in increased expression of SOD2 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [bifenthrin analog results in increased expression of SOD2 protein] bifenthrin results in increased expression of SOD2 mRNA |
CTD |
PMID:22718203 PMID:27916261 |
|
NCBI chr 1:47,638,318...47,645,163
Ensembl chr 1:47,636,528...47,645,189
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
affects binding |
ISO |
bifenthrin binds to SRC protein |
CTD |
PMID:32278787 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases expression |
ISO |
bifenthrin results in decreased expression of SRD5A2 mRNA |
CTD |
PMID:26071804 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Star |
steroidogenic acute regulatory protein |
multiple interactions decreases expression |
EXP ISO |
bifenthrin analog inhibits the reaction [CGA results in increased expression of STAR mRNA]; bifenthrin inhibits the reaction [CGA protein results in increased expression of STAR mRNA] bifenthrin results in decreased expression of STAR mRNA |
CTD |
PMID:21251947 PMID:21871944 PMID:23994515 |
|
NCBI chr16:66,267,094...66,274,368
Ensembl chr16:66,264,807...66,271,672
|
|
G |
Sult1e1 |
sulfotransferase family 1E member 1 |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of SULT1E1 mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr14:20,422,324...20,439,562
Ensembl chr14:20,422,324...20,439,275
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
bifenthrin results in increased expression of TFF1 mRNA |
CTD |
PMID:20097460 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tgfb1 |
transforming growth factor, beta 1 |
multiple interactions |
EXP |
bifenthrin inhibits the reaction [CGA protein results in increased expression of TGFB1 mRNA] |
CTD |
PMID:21251947 |
|
NCBI chr 1:81,196,532...81,212,848
Ensembl chr 1:81,196,532...81,212,847
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions decreases expression |
ISO EXP |
bifenthrin results in increased expression of TNF mRNA bifenthrin results in increased expression of TNF protein bifenthrin results in increased expression of TNF mRNA; bifenthrin results in increased expression of TNF protein bifenthrin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in increased expression of TNF mRNA] bifenthrin results in decreased expression of TNF mRNA |
CTD |
PMID:23172818 PMID:26071804 PMID:27916261 PMID:28251819 PMID:29775722 PMID:29793499 PMID:30102949 PMID:32061760 PMID:32408700 More...
|
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tp53 |
tumor protein p53 |
increases expression decreases expression |
ISO |
bifenthrin results in increased expression of TRP53 mRNA bifenthrin results in decreased expression of TRP53 mRNA |
CTD |
PMID:20097460 PMID:26071804 PMID:27916261 |
|
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
|
|
G |
Tspo |
translocator protein |
multiple interactions decreases expression |
EXP ISO |
bifenthrin analog inhibits the reaction [CGA results in increased expression of TSPO mRNA] bifenthrin results in decreased expression of TSPO mRNA |
CTD |
PMID:21871944 PMID:23994515 PMID:24449165 |
|
NCBI chr 7:114,720,188...114,730,450
Ensembl chr 7:114,720,188...114,730,450
|
|
|
G |
Ces1d |
carboxylesterase 1D |
multiple interactions increases hydrolysis increases metabolic processing |
ISO EXP |
27-hydroxycholesterol inhibits the reaction [CES1 protein results in increased metabolism of bioresmethrin] CES1 protein results in increased hydrolysis of bioresmethrin |
CTD |
PMID:16387282 PMID:19249324 PMID:19761868 |
|
NCBI chr19:13,873,490...13,912,035
Ensembl chr19:13,796,623...13,912,035
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
bioresmethrin results in increased expression of CYP3A4 mRNA |
CTD |
PMID:19249324 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO EXP |
bioresmethrin results in increased activity of NR1I2 protein bioresmethrin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:19249324 PMID:31538121 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
EXP |
bioresmethrin binds to and results in decreased activity of NR1I3 protein |
CTD |
PMID:31538121 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
|
G |
Cat |
catalase |
decreases expression |
EXP |
imiprothrin results in decreased expression of CAT protein |
CTD |
PMID:33638779 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases expression |
EXP |
imiprothrin results in increased expression of CYP1A2 mRNA |
CTD |
PMID:33638779 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
EXP |
imiprothrin results in increased expression of GPT protein |
CTD |
PMID:33638779 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
kadethrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression affects binding |
ISO |
phenothrin results in decreased expression of ESR1 protein phenothrin binds to ESR1 protein |
CTD |
PMID:15118252 PMID:32278787 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
decreases expression |
ISO |
phenothrin results in decreased expression of ESR2 protein |
CTD |
PMID:15118252 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
phenothrin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
EXP |
phenothrin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:31538121 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
multiple interactions |
ISO EXP |
phenothrin affects the localization of and results in increased activity of NR1I3 protein phenothrin binds to and results in decreased activity of NR1I3 protein |
CTD |
PMID:30247703 PMID:31538121 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Tff1 |
trefoil factor 1 |
multiple interactions increases expression |
ISO |
ICI 164384 inhibits the reaction [phenothrin results in increased expression of TFF1 mRNA] |
CTD |
PMID:10064545 PMID:15118252 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Vdr |
vitamin D receptor |
affects binding |
ISO |
phenothrin binds to VDR protein |
CTD |
PMID:32278787 |
|
NCBI chr 7:128,987,981...129,037,677
Ensembl chr 7:128,987,981...129,037,677
|
|
G |
Wnt10b |
Wnt family member 10B |
increases expression |
ISO |
phenothrin results in increased expression of WNT10B mRNA |
CTD |
PMID:12437293 |
|
NCBI chr 7:129,922,088...129,927,892
Ensembl chr 7:129,922,088...129,927,892
|
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
d,d-T80-prallethrin inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein] |
CTD |
PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bglap |
bone gamma-carboxyglutamate protein |
multiple interactions |
ISO |
d,d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 2:173,838,518...173,839,495
Ensembl chr 2:173,838,518...173,839,495
|
|
G |
Esr1 |
estrogen receptor 1 |
multiple interactions |
ISO |
d,d-T80-prallethrin binds to and results in decreased activity of ESR1 protein |
CTD |
PMID:33049310 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions |
ISO |
d,d-T80-prallethrin binds to and results in increased activity of ESR2 protein |
CTD |
PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fabp4 |
fatty acid binding protein 4 |
multiple interactions |
ISO |
d,d-T80-prallethrin promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 2:91,580,858...91,585,578
Ensembl chr 2:91,580,885...91,585,578
|
|
G |
Ins2 |
insulin 2 |
multiple interactions |
ISO |
d,d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of BGLAP mRNA]; d,d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA]; d,d-T80-prallethrin promotes the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of FABP4 mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 1:197,843,277...197,992,522
Ensembl chr 1:197,843,281...197,864,775
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
d,d-T80-prallethrin binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases expression multiple interactions |
ISO |
d,d-T80-prallethrin results in increased expression of PPARG mRNA d,d-T80-prallethrin binds to and results in increased activity of PPARG protein |
CTD |
PMID:32473317 PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Sp7 |
Sp7 transcription factor |
multiple interactions |
ISO |
d,d-T80-prallethrin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of SP7 mRNA] |
CTD |
PMID:32473317 |
|
NCBI chr 7:133,484,609...133,494,788
Ensembl chr 7:133,484,609...133,494,847
|
|
G |
Xbp1 |
X-box binding protein 1 |
increases activity |
ISO |
d,d-T80-prallethrin results in increased activity of XBP1 protein |
CTD |
PMID:20143881 |
|
NCBI chr14:80,390,629...80,395,713
Ensembl chr14:80,390,643...80,395,693
|
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
affects expression |
ISO |
Pyrethrins affects the expression of BAX protein |
CTD |
PMID:27939866 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
affects expression |
ISO |
Pyrethrins affects the expression of BCL2 protein |
CTD |
PMID:27939866 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Bdnf |
brain-derived neurotrophic factor |
multiple interactions |
ISO |
Pyrethrins inhibits the reaction [Potassium results in increased expression of BDNF mRNA] |
CTD |
PMID:15527870 |
|
NCBI chr 3:96,165,042...96,215,621
Ensembl chr 3:96,165,042...96,215,615
|
|
G |
Casp3 |
caspase 3 |
increases activity |
ISO |
Pyrethrins results in increased activity of CASP3 protein |
CTD |
PMID:27939866 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp9 |
caspase 9 |
increases activity |
ISO |
Pyrethrins results in increased activity of CASP9 protein |
CTD |
PMID:27939866 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Cat |
catalase |
increases activity |
EXP |
Pyrethrins results in increased activity of CAT protein |
CTD |
PMID:35678313 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression |
EXP |
Pyrethrins results in increased expression of CYP2B1 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases expression |
EXP |
Pyrethrins results in increased expression of CYP2B2 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
increases expression |
ISO |
Pyrethrins results in increased expression of CYP2B6 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases expression |
ISO |
Pyrethrins results in increased expression of CYP3A4 mRNA |
CTD |
PMID:18022748 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Fos |
Fos proto-oncogene, AP-1 transcription factor subunit |
multiple interactions |
ISO |
Pyrethrins inhibits the reaction [Potassium results in increased expression of FOS mRNA] |
CTD |
PMID:15527870 |
|
NCBI chr 6:105,121,170...105,124,036
Ensembl chr 6:105,121,170...105,124,036
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
affects activity |
EXP |
Pyrethrins affects the activity of GPT protein |
CTD |
PMID:35678313 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
Pyrethrins binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:21115097 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
increases cleavage |
ISO |
Pyrethrins results in increased cleavage of PARP1 protein |
CTD |
PMID:27939866 |
|
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
|
|
G |
Ppara |
peroxisome proliferator activated receptor alpha |
multiple interactions |
ISO |
Pyrethrins binds to and results in increased activity of PPARA protein |
CTD |
PMID:17084873 |
|
NCBI chr 7:116,832,405...116,900,878
Ensembl chr 7:116,832,756...116,895,346
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
decreases activity |
ISO |
resmethrin results in decreased activity of ABCG2 protein |
CTD |
PMID:23169446 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
G |
Amh |
anti-Mullerian hormone |
increases expression |
ISO |
resmethrin results in increased expression of AMH mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 7:8,906,776...8,909,184
Ensembl chr 7:8,906,836...8,909,282
|
|
G |
Ddx4 |
DEAD-box helicase 4 |
decreases expression |
ISO |
resmethrin results in decreased expression of DDX4 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 2:44,227,946...44,282,867
Ensembl chr 2:44,227,946...44,282,723
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding |
ISO |
resmethrin binds to ESR1 protein |
CTD |
PMID:32278787 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gfra1 |
GDNF family receptor alpha 1 |
decreases expression |
ISO |
resmethrin results in decreased expression of GFRA1 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 1:257,315,682...257,552,004
Ensembl chr 1:257,321,742...257,551,473
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
resmethrin results in increased activity of NR1I3 protein |
CTD |
PMID:28927721 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
resmethrin inhibits the reaction [Hydrocortisone results in increased activity of NR3C1 protein] |
CTD |
PMID:26647222 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
increases activity |
ISO |
resmethrin results in increased activity of PPARG protein |
CTD |
PMID:20143881 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Sohlh1 |
spermatogenesis and oogenesis specific basic helix-loop-helix 1 |
decreases expression |
ISO |
resmethrin results in decreased expression of SOHLH1 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 3:8,662,995...8,667,521
Ensembl chr 3:8,663,318...8,667,388
|
|
G |
Sohlh2 |
spermatogenesis and oogenesis specific basic helix-loop-helix 2 |
decreases expression |
ISO |
resmethrin results in decreased expression of SOHLH2 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 2:139,362,246...139,384,700
Ensembl chr 2:139,362,246...139,384,699
|
|
G |
Sox9 |
SRY-box transcription factor 9 |
increases expression |
ISO |
resmethrin results in increased expression of SOX9 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr10:97,806,485...97,811,994
Ensembl chr10:97,806,485...97,811,994
|
|
G |
Stra8 |
stimulated by retinoic acid 8 |
decreases expression |
ISO |
resmethrin results in decreased expression of STRA8 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 4:63,601,443...63,624,777
Ensembl chr 4:63,601,604...63,624,771
|
|
G |
Sycp3 |
synaptonemal complex protein 3 |
decreases expression |
ISO |
resmethrin results in decreased expression of SYCP3 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 7:22,874,055...22,888,512
Ensembl chr 7:22,874,055...22,888,511
|
|
G |
Tsc22d3 |
TSC22 domain family, member 3 |
multiple interactions |
ISO |
resmethrin inhibits the reaction [Hydrocortisone results in increased expression of TSC22D3 mRNA] |
CTD |
PMID:26647222 |
|
NCBI chr X:104,217,898...104,277,935
Ensembl chr X:104,217,925...104,276,861
|
|
G |
Wt1 |
WT1 transcription factor |
increases expression |
ISO |
resmethrin results in increased expression of WT1 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 3:91,566,540...91,613,653
Ensembl chr 3:91,567,001...91,613,643
|
|
G |
Zbtb16 |
zinc finger and BTB domain containing 16 |
decreases expression |
ISO |
resmethrin results in decreased expression of ZBTB16 mRNA |
CTD |
PMID:31593228 |
|
NCBI chr 8:48,989,376...49,177,011
Ensembl chr 8:48,994,566...49,177,011
|
|
|
G |
Ar |
androgen receptor |
multiple interactions decreases expression |
ISO |
tetramethrin results in decreased activity of [Dihydrotestosterone results in increased activity of AR protein] tetramethrin results in decreased expression of AR mRNA |
CTD |
PMID:12711008 PMID:16621434 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Brca1 |
BRCA1, DNA repair associated |
affects binding |
ISO |
tetramethrin binds to BRCA1 protein |
CTD |
PMID:32278787 |
|
NCBI chr10:86,417,441...86,477,762
Ensembl chr10:86,418,000...86,477,304
|
|
G |
Ces2h |
carboxylesterase 2H |
multiple interactions increases metabolic processing |
ISO |
CES2 protein inhibits the reaction [tetramethrin results in increased activity of NR1I2 protein] CES2 protein results in increased metabolism of tetramethrin |
CTD |
PMID:19249324 |
|
NCBI chr19:32,974,242...32,988,842
Ensembl chr19:32,974,242...32,988,830
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
CYP3A4 protein results in increased metabolism of tetramethrin |
CTD |
PMID:19249324 |
|
NCBI chr12:9,207,986...9,230,038
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Esr1 |
estrogen receptor 1 |
decreases expression |
EXP |
tetramethrin results in decreased expression of ESR1 protein |
CTD |
PMID:16326440 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
increases expression |
EXP |
tetramethrin results in increased expression of ESR2 protein |
CTD |
PMID:16326440 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Folh1 |
folate hydrolase 1 |
decreases expression |
ISO |
tetramethrin results in decreased expression of FOLH1 mRNA |
CTD |
PMID:12711008 |
|
NCBI chr 1:140,428,101...140,501,563
Ensembl chr 1:140,428,101...140,501,379
|
|
G |
Igf1 |
insulin-like growth factor 1 |
multiple interactions |
ISO |
tetramethrin inhibits the reaction [IGF1 protein results in increased import of Calcium] |
CTD |
PMID:1550224 PMID:2460452 PMID:2539779 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Igf2 |
insulin-like growth factor 2 |
multiple interactions |
ISO |
tetramethrin inhibits the reaction [IGF2 protein results in increased import of Calcium] |
CTD |
PMID:2442157 PMID:2539779 |
|
NCBI chr 1:197,814,409...197,831,802
Ensembl chr 1:197,814,410...197,823,018
|
|
G |
Kcnh2 |
potassium voltage-gated channel subfamily H member 2 |
decreases activity |
ISO |
tetramethrin results in decreased activity of KCNH2 protein |
CTD |
PMID:28551711 |
|
NCBI chr 4:10,826,834...10,859,009
Ensembl chr 4:10,826,928...10,859,008
|
|
G |
Nkx3-1 |
NK3 homeobox 1 |
decreases expression |
ISO |
tetramethrin results in decreased expression of NKX3-1 mRNA |
CTD |
PMID:12711008 |
|
NCBI chr15:44,473,851...44,476,443
Ensembl chr15:44,473,851...44,476,441
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO EXP |
CES2 protein inhibits the reaction [tetramethrin results in increased activity of NR1I2 protein] |
CTD |
PMID:19249324 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
multiple interactions |
ISO |
[Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin co-treated with propylparaben] results in increased activity of NR3C1 protein; [Diethylhexyl Phthalate co-treated with butylparaben co-treated with tetramethrin] results in increased activity of NR3C1 protein; [tetramethrin co-treated with propylparaben] results in increased activity of NR3C1 protein |
CTD |
PMID:25448277 |
|
NCBI chr18:31,271,681...31,393,320
Ensembl chr18:31,271,681...31,393,375
|
|
G |
S100g |
S100 calcium binding protein G |
decreases expression multiple interactions |
EXP |
tetramethrin results in decreased expression of S100G mRNA tetramethrin inhibits the reaction [Estradiol results in increased expression of S100G mRNA] |
CTD |
PMID:16326440 |
|
NCBI chr X:31,705,853...31,708,422
Ensembl chr X:31,705,866...31,708,433
|
|
G |
Shbg |
sex hormone binding globulin |
affects binding |
ISO |
tetramethrin binds to SHBG protein |
CTD |
PMID:32278787 |
|
NCBI chr10:54,332,939...54,350,409
Ensembl chr10:54,332,941...54,351,057
|
|